Related Experiment Video
Updated: Oct 29, 2025

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Prevalence of bradyarrhythmias needing pacing in COVID-19
Zaki Akhtar1,2, Lisa Wm Leung1, Christos Kontogiannis1
1Cardiology, St George's University Hospital NHS trust, London, UK.
Insights
The COVID-19 pandemic did not alter the prevalence of high-degree atrioventricular block, a type of bradyarrhythmia. Pacemaker implants for bradyarrhythmia were lower during the pandemic, with no cases of transient atrioventricular block linked to Sars-Cov-2 infection.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Severe Acute Respiratory Syndrome-Coronavirus-2 (Sars-Cov-2) infection, the cause of COVID-19, is a multisystem illness impacting the cardiovascular system.
- While tachyarrhythmias are reported, the prevalence of bradyarrhythmia, including high-degree atrioventricular (AV) block, in COVID-19 patients remains unclear.
- Transient high-degree AV block has been described in some COVID-19 cases, often managed conservatively.
Purpose of the Study:
- To investigate the prevalence of high-degree atrioventricular block requiring pacemaker implantation during the COVID-19 pandemic.
- To compare pacemaker implantation rates for bradyarrhythmia during the first year of the pandemic versus the preceding year.
- To determine if Sars-Cov-2 infection is associated with transient high-degree AV block.
Main Methods:
- A retrospective analysis of patients requiring temporary or permanent pacemaker implantation in two cardiac centers.
- Comparison of pacemaker procedures during the initial year of the COVID-19 pandemic with the corresponding period in the prior year.
- Cross-referencing pacemaker databases with COVID-19 testing results to identify infected patients requiring pacing.
Main Results:
- The total number of new pacemaker implants decreased during the pandemic year (540) compared to the previous year (629).
- The proportion of high-degree AV block among new implants remained similar between the two periods (38.3% vs. 33.2%, p=0.069).
- Six patients with Sars-Cov-2 infection required pacemaker implantation for bradyarrhythmia (four for high-degree AV block, two for sinus node dysfunction); two died from COVID-19, and one from sepsis.
Conclusions:
- The prevalence of high-degree AV block requiring pacemaker implantation was not altered by the COVID-19 pandemic.
- No evidence of transient high-degree AV block specifically associated with Sars-Cov-2 infection was found in this study.
- Clinically significant bradyarrhythmia should be managed with pacing according to established protocols, irrespective of COVID-19 status.
Background:
The Sars-Cov-2 infection is a multisystem illness that can affect the cardiovascular system. Tachyarrhythmias have been reported but the prevalence of bradyarrhythmia is unclear. Cases have been described of transient high-degree atrioventricular (AV) block in COVID-19 that were managed conservatively.
Method:
A database of all patients requiring temporary or permanent pacing in two linked cardiac centers was used to compare the number of procedures required during the first year of the pandemic compared to the corresponding period a year earlier. The database was cross-referenced with a database of all patients testing positive for Sars-Cov-2 infection in both institutions to identify patients who required temporary or permanent pacing during COVID-19.
Results:
The number of novel pacemaker implants was lower during the COVID-19 pandemic than the same period the previous year (540 vs. 629, respectively), with a similar proportion of high-degree AV block (38.3% vs. 33.2%, respectively, p = .069). Four patients with the Sars-Cov-2 infection had a pacemaker implanted for high-degree AV block, two for sinus node dysfunction. Of this cohort of six patients, two succumbed to the COVID-19 illness and one from non-COVID sepsis. Device interrogation demonstrated a sustained pacing requirement in all cases.
Conclusion:
High-degree AV block remained unaltered in prevalence during the COVID-19 pandemic. There was no evidence of transient high-degree AV block in patients with the Sars-Cov-2 infection. Our experience suggests that all clinically significant bradyarrhythmia should be treated by pacing according to usual protocols regardless of the COVID status.
More Related Videos
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Mechanism of Cardiac Arrhythmias